查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620345

光生物刺激設備市場：依類型、應用、最終用戶、地區劃分，2024-2031

Photobiostimulation Devices Market By Type (Infrared Light, Red Light), Application (Pain Management, Wound Care, Cosmetics Applications), End User (Specialty Clinics, Research Institutes, Home Care) & Region for 2024-2031
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

光生物刺激設備的市場評估，2024-2031

非侵入性、無藥物治療技術的發展趨勢，以及人們對其功效和安全性的認識不斷提高，正在推動對光生物刺激設備的需求。據 Verified Market Research 分析師稱，預測期內光學生物刺激設備市場估值預計將達到 3.1364 億美元，低於 2023 年的約 1.9582 億美元。

隨著醫療保健專業人士和消費者意識到光生物刺激療法的好處，市場正在加速發展，促使這些設備在各種醫療環境中的使用不斷增加，預計從2024 年起將會增長，這使得市場的複合年增長率達到6.07。

光生物刺激設備市場定義/概述

光生物刺激裝置，也稱為低強度雷射療法 (LLLT) 或冷激光，使用特定波長的光來激活體內的細胞過程。這些設備產生非熱、低強度的光，被細胞吸收並引發各種生化反應，促進癒合和組織再生。簡而言之，光生物刺激利用光的治療特性來刺激身體的自然癒合過程，而不會傷害身體。

此外，這些設備也用於各種醫療和美容領域。在醫療保健中，它用於控制關節炎、肌腱炎和運動損傷等疾病引起的疼痛，減少炎症，緩解肌肉骨骼疼痛。光生物刺激裝置也已用於傷口癒合，以促進糖尿病潰瘍等急慢性傷口的早期恢復。

哪些因素推動光生物刺激裝置的發展？

世界人口越來越受到神經性疼痛、肌肉骨骼疾病和關節炎等慢性疾病的影響。因此，光生物刺激裝置可以幫助控制疼痛、減少發炎並促進各種環境下的組織癒合，從而增加了對此類治療方案的需求。

用於疼痛管理和復健的非侵入性方法正在獲得醫療保健專業人員和患者的廣泛接受。這一趨勢得到了越來越多的臨床證據的支持，證明了光生物刺激療法的有效性和安全性，從而促進了其越來越多的採用。

此外，雷射和 LED 技術的不斷進步正在開發更有效、便攜式且易於使用的光生物刺激設備。這些技術進步不僅提高了治療效果，而且使其更適合家庭使用，從而促使市場成長。

限制光學生物刺激設備市場成長的限制是什麼？

儘管光生物刺激設備具有潛在的好處，但醫療專業人士和消費者都對它們持懷疑態度。說服醫療保健提供者和患者使用新技術可能具有課題性，特別是當人們對這些設備的工作原理知之甚少時。結果，它已成為市場的主要障礙。

獲得光生物刺激療法的保險報銷也可能是個問題。許多保險公司對接受新的或正在開發的治療方法持謹慎態度，除非有強有力的證據表明成本效益或長期效益。這限制了患者獲得這些藥物的機會，使得某些治療對某些患者來說自付費用過於昂貴。

此外，美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構的批准也是一大障礙。這些設備必須滿足高安全性和有效性要求，並且審批過程既耗時又昂貴。

目錄

第一章光生物刺激設備的全球市場：簡介

  • 市場概覽
  • 調查範圍
  • 先決條件

第 2 章執行摘要

第三章驗證市場研究研究方法

  • 資料探勘
  • 驗證
  • 初步面試
  • 資料來源列表

第 4 章光生物刺激設備的全球市場前景

  • 摘要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第五章光生物刺激設備的全球市場：依類型

  • 摘要
  • 紅外線
  • 紅燈
  • 其他

第 6 章光生物刺激設備的全球市場：依應用分類

  • 摘要
  • 疼痛管理
  • 傷口治療
  • 化妝品應用
  • 其他

第 7 章光生物刺激設備的全球市場：按最終用戶劃分

  • 專科診所
  • 研究院
  • 家庭醫療護理
  • 其他

第 8 章全球光生物刺激設備市場：競爭格局

  • 摘要
  • 各公司的市場排名
  • 主要發展策略

第九章公司簡介

  • Lumenis
  • BIOPTRON AG
  • PhotoMedex Inc.
  • Zimmer Biomet
  • IRRAS
  • LiteCure LLC
  • Mettler Electronics Corp.
  • TheraLight LLC
  • Quantum Devices Inc.
  • Diomed Medical Group

第10章主要進展

  • 產品發佈/開發
  • 併購
  • 業務擴展
  • 合作夥伴與聯盟

第11章附錄

  • 相關研究
簡介目錄
Product Code: 11397

Photobiostimulation Devices Market Valuation - 2024-2031

The growing inclination toward non-invasive and drug-free therapeutic techniques is driven by increased awareness of their efficacy and safety, fueling demand for photobiostimulation devices. According to the analyst from Verified Market Research, the Photobiostimulation Devices Market is estimated to reach a valuation of USD 313.64 Million over the forecast subjugating aroundUSD 195.82 Million valued in 2023.

The market is gaining pace as healthcare professionals and consumers recognize the benefits of photobiostimulation therapy, resulting in increased usage of these devices in a variety of healthcare settings and enabling the market to grow at aCAGR of 6.07% from 2024 to 2031.

Photobiostimulation Devices Market: Definition/ Overview

Photobiostimulation devices, also known as low-level laser treatment (LLLT) or cold lasers, use certain wavelengths of light to activate cellular processes in the body. These devices produce non-thermal, low-intensity light that is absorbed by cells, resulting in a variety of biochemical responses that promote healing and tissue regeneration. In essence, photobiostimulation uses the therapeutic characteristics of light to accelerate the body's natural healing processes without causing harm.

Furthermore, these devices are utilized in a variety of medical and aesthetic disciplines. They are used in healthcare to control pain, reduce inflammation, and relieve musculoskeletal pain caused by illnesses such as arthritis, tendonitis, and sports injuries. Photobiostimulation devices are also used in wound healing to promote speedier recovery from both acute and chronic wounds, such as diabetic ulcers.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which are the Drivers Fostering Growth of Photobiostimulation Devices?

The world's population is becoming more and more affected by chronic illnesses such as neuropathic pain, musculoskeletal disorders, and arthritis. As a result, photobiostimulation devices help manage pain, decrease inflammation, and encourage tissue healing in various situations, increasing the demand for such therapeutic options.

Non-invasive methods for pain management and rehabilitation have gained substantial traction among healthcare professionals and patients. This trend is supported by a rising amount of clinical evidence demonstrating the efficacy and safety of photobiostimulation therapy, contributing to its increasing adoption.

Furthermore, continuous advancements in laser and LED technology have resulted in the creation of more effective, portable, and user-friendly photobiostimulation devices. These technical advancements not only improve therapeutic efficacy but also make these devices more accessible for home use, hence growing the market.

Which are the Limitations Restraining Growth of Photobiostimulation Devices Market?

Despite their potential benefits, photobiostimulation devices are viewed skeptically by both the medical establishment and consumers. Convincing healthcare providers and patients to use new technology is tough, especially when there is little awareness or comprehension of how these devices work. As a result, it acts as a significant obstacle for the market.

Obtaining insurance reimbursement for photobiostimulation therapies is possible to be problematic. Many insurance companies are cautious to accept novel or developing treatments unless there is strong evidence of their cost-effectiveness and long-term benefits. This limits patient access to these medicines because some treatments may be prohibitively expensive for some patients to pay out of pocket.

Furthermore, approval from regulatory organizations such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) is a substantial barrier. These devices have to satisfy high safety and efficacy requirements, and the approval process can be lengthy and expensive.

Category-Wise Acumens

How will Sales of Infrared Light Fare for The Market?

According to VMR analysis, the infrared light segment is estimated to hold the largest market share in the type segment during the forecast period. Infrared light treatment is used for a variety of purposes, including pain relief, inflammation reduction, muscle repair, and wound healing. Its versatility appeals to a wide range of users, including medical professionals, physical therapists, and patients seeking at-home therapy choices. This diverse range of applications helps to explain the reason infrared light devices are more widely used than other types of photobiostimulation devices.

Infrared light penetrates deeper into tissues than red light or other forms of light utilized in photobiostimulation. This deeper penetration is critical for treating problems that occur in deeper layers of tissue, making infrared devices particularly beneficial for a wide range of medical and therapeutic applications, including muscle discomfort, joint issues, and certain types of chronic pain. The capacity to penetrate deeper tissues increases the utility and effectiveness of infrared photobiostimulation devices, contributing to their dominant market position.

Furthermore, infrared light therapy's efficacy and safety have been validated by extensive clinical evidence, resulting in regulatory approval for a wide range of medical and therapeutic applications. This robust clinical backing reassures both healthcare providers and patients, encouraging the use of infrared light equipment. Regulatory approvals also assist the introduction of these technologies into mainstream healthcare settings, increasing their market penetration.

Which Drivers Boost Applications of Pain Management in the Market?

The pain management segment is estimated to grow at the highest CAGR in the Photobiostimulation Devices Market during the forecast period. The rising prevalence of chronic pain diseases such as arthritis, back pain, and neck pain, among others, adds significantly to the demand for pain management solutions. Photobiostimulation devices provide a non-invasive, drug-free pain relief option that appeals to a diverse variety of individuals seeking alternatives to pharmaceutical pain management.

Photobiostimulation devices are becoming increasingly popular among healthcare practitioners for pain management. This is due to a substantial body of clinical evidence demonstrating their usefulness in pain management and tissue healing. As these devices become more integrated into normal pain management protocols, their market share in this segment is increasing.

Furthermore, technological improvements have improved the effectiveness, affordability, and accessibility of photobiostimulation devices. Innovations in device design, such as portability and ease of use, have allowed patients to utilize these devices at home, increasing their popularity for pain management.

Country/Region-wise Acumens

Which Drivers Support North America's Dominant Position in the Market?

According to VMR analyst, North America is estimated to dominate the Photobiostimulation Devices Market during the forecast period. North America is demonstrating an increasing preference for non-invasive treatment choices. Photobiostimulation devices, which offer a non-invasive technique for controlling chronic pain, wound healing, and cosmetic applications, connect well with this trend and are becoming increasingly popular in the region.

North America is home to several competitors in the market, contributing to the region's dominant position in the photobiostimulation device market. The region's inclination towards adopting technologically advanced, minimally invasive therapies promoting the development and use of photobiostimulation devices. The region's strong healthcare infrastructure and high healthcare expenditure support market growth.

Furthermore, the regulatory framework in North America, particularly in the United States, promotes innovation and speedy clearance of medical devices, including photobiostimulation devices. This environment stimulates companies to create and commercialise innovative and effective therapies, boosting market growth.

What Variables Influence the Demand for these Devices in Asia Pacific Region?

Asia Pacific is estimated to grow at the highest CAGR within the market during the forecast period. Asia Pacific has a large and expanding elderly population, making it more vulnerable to chronic illnesses that can be addressed using photobiostimulation devices, such as pain relief, wound treatment, and cosmetic applications. As these illnesses become more common, there is a greater need for photobiostimulation therapy.

Countries in Asia Pacific, particularly China and India, are experiencing significant economic expansion, resulting in higher healthcare spending. Such economic growth has increased access to healthcare services and modern medical technologies, such as photobiostimulation devices.

Furthermore, this region is experiencing an increase in the use of non-invasive treatments. Photobiostimulation devices are a non-invasive alternative to standard medical treatments for a range of illnesses, matching patient preferences and driving market expansion in the region.

Competitive Landscape

The Photobiostimulation Devices Market is characterized by dynamic interactions between numerous companies competing for market share. Market companies are constantly striving to differentiate themselves by developing innovative photobiostimulation devices with improved efficacy, safety features, and usability.

Some of the prominent players operating in the Photobiostimulation Devices Market include:

Lumenis, BIOPTRON AG, PhotoMedex Inc., Zimmer Biomet, IRRAS, LiteCure LLC, Mettler Electronics Corp., TheraLight LLC, Quantum Devices Inc., Diomed Medical Group, Aktiia, BIOLUX, INTERNATIONAL CORP., CellGen Therapeutics, Cytalux Corporation, LED Medical Diagnostics Inc., LG Innotek, Koninklijke Philips N.V., MOSER BAER AG, PhotoSonix Medical Inc., and Verilux Inc.

Latest Developments

In February 2024, BIOPTRON AG presented positive clinical data on the use of photobiostimulation treatment devices for wound healing at the Dubai World Dermatology Congress. The study discovered that the therapy dramatically decreased healing time while improving patient outcomes.

In February 2024, MOSER BAER announced an increase in its LED manufacturing capacity to accommodate the growing demand for photobiostimulation devices. This investment will allow the company to help its customers grow in this area.

In January 2024, PhotoMedex established a strategic agreement with Zimmer Biomet to develop and commercialise photobiostimulation devices for orthopaedic purposes. This alliance aims to harness both organisations' expertise to bring innovative ideas to market.

In October 2023, Philips announced a collaboration with the University of Amsterdam to investigate the use of photobiostimulation to treat brain problems. This collaboration seeks to investigate the potential of this technology for neurological applications.

In October 2023, Lumenis announced the Aculight(TM) Cynosure Laser System, a photobiostimulation therapy device to treat chronic pain and inflammation. The company says that the system has deeper tissue penetration and faster treatment times than previous models.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Infrared Light
  • 5.3 Red Light
  • 5.4 Others

6 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Pain Management
  • 6.3 Wound Care
  • 6.4 Cosmetic Applications
  • 6.5 Others

7 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET, BY END USER

  • 7.1 Specialty Clinics
  • 7.2 Research Institutes
  • 7.3 Home Care
  • 7.4 Others

8 GLOBAL PHOTOBIOSTIMULATION DEVICES MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Lumenis
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 BIOPTRON AG
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 PhotoMedex Inc.
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Zimmer Biomet
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 IRRAS
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 LiteCure LLC
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key DevelopmentS
  • 9.7 Mettler Electronics Corp.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 TheraLight LLC
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Quantum Devices Inc.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Diomed Medical Group
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research